This is a preview of subscription content, log in via an institution to check access.
Reference
FDA issues final decision to withdraw approval of Pepaxto (melphalan flufenamide) Internet Document : 23 Feb 2024. Available from: URL: https://www.fda.gov/drugs/drug-safety-and-availability/fda-issues-final-decision-withdraw-approval-pepaxto-melphalan-flufenamide
Rights and permissions
About this article
Cite this article
FDA withdraws approval of melphalan flufenamide. Reactions Weekly 1997, 5 (2024). https://doi.org/10.1007/s40278-024-53686-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-53686-x